Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

Buy-and-Bill

COVID-19

Case-Based Roundtable

Chronic Hand Eczema

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Prurigo Nodularis

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Perspectives in Dermatology

Polls

Editorial Advisory Board

Partners

Subscribe

Articles

QRPs are key to dermatologists' retirement plans—learn the benefits, drawbacks, and how to choose the best strategy for your financial goals.

Retirement Plans 101: What Dermatologists Need to Know

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Daily Derm Times: April 17, 2025

Pelthos and Channel Therapeutics will merge to form a new publicly traded entity focused on commercializing the first at-home treatment for molluscum.

Channel Therapeutics and Pelthos Therapeutics to Merge to Accelerate Launch of Zelsuvmi for Molluscum Contagiosum

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and is now finishing her Masters in Digital Media through Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family.

Having multiple therapeutic options would allow clinicians to tailor treatment and offer hope to patients who don't respond initially.

Hope on the Horizon: FDA to Weigh in on Dupilumab for CSU

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

1rem

Authors

Online-first engagement ensures patients obtain the right care for their specific needs.

 How a digital front door can improve patients’ access to care

Final Thoughts: The Importance of Comparative Studies in AD

Panelists offer concluding insights and emphasize the critical role of comparative studies in advancing atopic dermatitis treatment strategies.

clinical

Video Series

A recent study reviewed cosmeceutical trends on social media and discovered that retinol is the most searched cosmeceutical on several platforms.

Investigators used analytics from TikTok and Google Trends. It is estimated that between 45% and 50% of adults turn to social media for skin care advice.

The authors conducted a Google Trends search from January 2004 to December 2023 in the United States. Trend lines were created for terms like retinol, bakuchiol, salicylic acid, glycolic acid, azelaic acid, hydroquinone, niacinamide, vitamin C serum, and hyaluronic acid. Then, the yearly perfect differences in relative search volume index (SVI) were calculated. The SVI is the ratio of the frequency a term is searched within a specific time relative to peak search volume during that time frame. An SVI of 100 is the peak popularity of the term. These trends were then graphed on scatterplots and compared to the total number of TikTok views for each search term.

The largest twofold increase in cosmeceutical search volume occurred from 2020 to 2021, due to the COVID-19 pandemic. Here, the average SVI doubled or tripled, with some increasing by 40% or more. Between 2022 and 2023, search volume rose by over 18%. This search interest in trends will continue to increase over time, according to the data.

Retinol was the most popular on both platforms followed by hyaluronic acid, salicylic acid, glycolic acid, vitamin C, niacinamide, hydroquinone, and azelaic acid. Retinol had an interest rank of 1 based on both Google SVI and TikTok views, the highest of all the cosmeceuticals. Bakuchiol was the least popular search term. Interestingly, niacinamide had much more TikTok views than Google searches. Conversely, salicylic acid had a higher Google SVI and a lower amount of TikTok viewership.

“Although not perfectly aligned, these data results collectively reveal that cosmeceutical appeal is constantly increasing, and that interest correlates with consumer viewership on social media,” the authors wrote.

The data may not accurately characterize all of the public interest due to some study limitations, including the lack of Internet access for older populations or those with lower socioeconomic status. Additionally, although Google Trends can be localized to certain geographic regions, TikTok cannot. Future literature could further evaluate specific demographics.

These results emphasize patients’ public interest in skin care, specifically with cosmeceuticals. Clinicians are advised to stay informed on popular social media trends so that they can educate their patients on product usage and combat misinformation.

“Awareness of skincare trends and growth in cosmeceutical interest empower dermatologists to anticipate patient inquiries and develop targeted education on product efficacy, cost effectiveness, and potential adverse reactions,” the authors wrote.

Let us know your thoughts and experiences by answering our poll above and commenting on social media, or by writing to us at 

1. Correia E, Mandel J, Cullison SRJ. Analyzing Social Media Trends in Cosmeceuticals: Insights From Google Trends and TikTok Analytics. 

. 2025;24(4):e70172. doi:10.1111/jocd.70172

2. Yousaf A, Hagen R, Delaney E, Davis S, Zinn Z. The influence of social media on acne treatment: A cross-sectional survey. 

2020;37(2):301-304. doi:10.1111/pde.14091

A study analyzed cosmeceutical trends on social media, revealing retinol as the most searched term on platforms like TikTok and Google. The research utilized Google Trends data from 2004 to 2023, showing a significant increase in search volume during the COVID-19 pandemic. Retinol, hyaluronic acid, and salicylic acid were among the top searched terms. The study highlights the growing public interest in cosmeceuticals and suggests that clinicians should stay informed about social media trends to educate patients effectively and address misinformation.

Google search trends and TikTok view counts were used to analyze the public popularity of cosmeceutical ingredients like retinol, hyaluronic acid, and niacinamide.

POLL: Which Cosmeceuticals Are Most Popular, According to Social Media?

 series, host Renata Block, MMS, PA-C, a board-certified physician assistant in Chicago, Illinois, and a 

 Editorial Advisory Board member, and guest Peter Lio, MD, a board-certified dermatologist and clinical assistant professor of dermatology and pediatrics at the Northwestern Feinberg School of Medicine in Chicago, Illinois, discuss integrative approaches to managing eczema, including the use of holistic treatments, and how to incorporate these methods alongside conventional therapies.

In the first Derm Dispatch episode, Renata Block, MMS, PA-C, and Peter Lio, MD, discuss integrative approaches to managing eczema, including the use of holistic treatments.  

Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine 

Lio, a dermatologist specializing in integrative approaches, emphasizes that good clinical care often naturally incorporates individualized care, blending conventional and holistic methods. One evidence-based approach he highlights is black tea compresses, which help reduce inflammation and itch, offering a simple, cost-effective alternative to bleach baths.

Lio acknowledges that while integrative options such as probiotics and vitamin D supplementation can be beneficial, patient receptivity varies. He tailors recommendations to individual preferences, avoiding overwhelming patients with too many interventions. He also discusses the nuanced role of bleach baths, noting that while they are still guideline-recommended, their mechanism may be more anti-inflammatory than antimicrobial.

Addressing steroid dependency, Lio shares his balanced perspective, recognizing their necessity in certain cases but advocating for safer, long-term alternatives. He also touches on dietary influences, emphasizing that while food triggers are rare, an anti-inflammatory diet, such as the autoimmune protocol diet, may provide some benefit. However, he cautions against unnecessary food elimination, which may increase the risk of true allergies. His patient-centered approach prioritizes evidence-based strategies while respecting individual preferences.

Block and Lio also discuss the hygiene hypothesis, noting that modern lifestyles and exposure to detergents, emulsifiers, and pollutants may negatively impact the skin barrier and microbiome. With probiotics, Lio emphasizes that although evidence is mixed, multi-strain formulations such as 

 show promise, particularly in prevention.

Lio advocates for a holistic strategy, integrating stress management techniques such as hypnotherapy and meditation, recognizing the bidirectional relationship between stress and skin inflammation.

He also shares his excitement about the growth of integrative dermatology, highlighting initiatives such as the Integrative Dermatology Symposium and the "Living Well With Eczema: A Community Workshop" event in Chicago to support education, connection, and personalized care strategies.

“We think it's so important to get these words out there. So many families feel isolated and alone. The magic is when they come together, they get to know each other, they see that they're not alone, and other people are going through the struggle. They share tips and tricks. They meet people. It's really lovely. We do something like this on the national level every year with the Eczema Expo, but this is something a little bit more intimate on a local level. We're hoping if it's a big hit here in Chicago, we're going to do more of these in different parts of the country so people can get something a little bit closer to home,” Lio said.

The “Living Well With Eczema: A Community Workshop” event, hosted by the National Eczema Association on March 22nd, brought together patients, caregivers, and health care providers for a day-long workshop to discuss eczema management strategies. Registration to the event included access to eczema sessions led by experts, educational resource packets, and networking opportunities.

register to attend Revolutionizing Atopic Dermatitis

 in Nashville, Tennessee, June 6-7. Use code DT40 for 40% off your RAD 2025 registration.

In the first Derm Dispatch episode, Renata Block, MMS, PA-C, and Peter Lio, MD, discuss integrative approaches to managing eczema, including the use of holistic treatments.

Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine

“Chronic hand eczema can be a tricky diagnosis and a tricky thing to treat, in part because we don't always agree on what the diagnosis is. As long as you've had multiple bouts of eczema on your hands in one year, or a particular symptom of patterns that have been going on for at least 3 months, you really fit the bill for chronic hand eczema,” said Raj Chovatiya, MD, PhD, MSCI, in an interview with 

Chovatiya, a board-certified dermatologist and clinical associate professor at Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research in Chicago, and a 

 Editorial Advisory Board member, recently discussed his approach to diagnosing and treating chronic hand eczema (CHE).

Raj Chovatiya, MD, PhD, MSCI, discusses his approach to diagnosing and treating chronic hand eczema.  

Addressing Diagnostic Ambiguity and Expanding Therapeutic Options in CHE 

CHE is a heterogeneous skin condition characterized mainly by 3 main etiologies: irritant contact dermatitis, allergic contact dermatitis, and atopic hand eczema. Each etiology has its own unique immune signature, and the condition can be overall difficult to treat, particularly in moderate to severe cases.

As Chovatiya noted, CHE can be difficult to diagnose due to the 3 etiologies not always predicting the way the condition will present on the hands. Generally, CHE can be defined by recurrent episodes of hand eczema over the span of a year or a persistent pattern lasting at least 3 months, according to Chovatiya.

He also noted that clinicians frequently face uncertainty about whether to treat CHE as contact dermatitis, atopic dermatitis, or a combination, and how extensively to pursue diagnostics. Chovatiya’s approach recommends starting with foundational strategies: barrier care with emollients, trigger avoidance, and limiting wet-to-dry exposure.

For initial pharmacologic treatment, topical corticosteroids or calcineurin inhibitors are appropriate. If patients show insufficient response after a few weeks of consistent use, escalation should be considered. Chovatiya anticipates delgocitinib, a topical pan-JAK inhibitor, will be a valuable next-line therapeutic given its ability to target multiple inflammatory pathways involved in CHE.

Regarding diagnostics, Chovatiya supports a selective approach to patch testing, particularly for patients with occupational exposures, refractory disease, or unclear clinical patterns. However, he cautioned against withholding treatment while awaiting diagnostic results.

In refractory cases, advanced therapies such as systemic immunosuppressants, phototherapy, or oral retinoids (e.g., alitretinoin, outside the US) may be warranted. While clinicians often turn to atopic dermatitis treatments such as biologics and oral JAK inhibitors, their efficacy in CHE is variable, demonstrating the need for therapies specifically approved for CHE.

To learn more about CHE and atopic dermatitis from Dr Chovatiya, 

register to attend Revolutionizing Atopic Dermatitis (RAD)

Dubin C, Del Duca E, Guttman-Yassky E. Drugs for the treatment of chronic hand eczema: successes and key challenges. 

. 2020 Dec 31;16:1319-1332. doi: 10.2147/TCRM.S292504

Raj Chovatiya, MD, PhD, MSCI, discusses his approach to diagnosing and treating chronic hand eczema. 

Addressing Diagnostic Ambiguity and Expanding Therapeutic Options in CHE

In early 2024, Clinique Laboratories made a donation of $5M to the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine to study and better understand healthy skin. The philanthropic partnership established the Mount Sinai-Clinique Healthy Skin Center, a virtual research enterprise with Emma Guttman-Yassky, MD, PhD, Chair of the Waldman Department of Dermatology, as the inaugural director. One year later, we take a look at the unique story behind this special philanthropic partnership and what it has enabled in the Center’s first year of existence.

The story behind this donation is about two entities—a leading global prestige beauty brand and an academic medical research center—recognizing a kindred spirit in each other, despite some core differences. Since its origin in 1968, safety for sensitive skin has been the heart of Clinique’s mission. Dr. Norman Orentreich, the first President of the American Society for Dermatologic Surgery and Clinique’s Founding Dermatologist was highly invested in allergy science. He pioneered Clinique’s allergy testing program; to date, Clinique has conducted over 6 million allergy-testing applications.

Norman’s son, David S. Orentreich, MD, is an Assistant Clinical Professor, Voluntary Attending for the Department of Dermatology at the Icahn School of Medicine at Mount Sinai. Together with his sister Catherine Orentreich, MD, he is also continuing his father’s legacy as Guiding Dermatologists for Clinique. Having a deep understanding of Clinique’s brand mission to support healthy skin research, Dr David Orentreich introduced Clinique’s head of Product Development to Dr. Emma Guttman, knowing she is a world-renowned expert in allergic and inflammatory skin diseases and was working on new and meaningful research at Mount Sinai. From the first conversation with Dr. Guttman, Clinique realized that a gift to establish a healthy skin center at Mount Sinai that would support this scientific research was a natural continuation of the Clinique brand mission to create great skin for all.

The Mount Sinai-Clinique Healthy Skin Center was announced in February 2024 with the ambitious aim of learning more about the aging process and how to best tackle it in different stages of life by examining healthy patients alongside those with inflammatory skin conditions like atopic dermatitis. Studying the impact of factors like diet, exercise, and stress on the skin of healthy people provided Mount Sinai’s scientists with key insights on how to turn back the clock on aging and the effects of inflammation on skin. The Department of Dermatology at Mount Sinai serves the world’s most diverse patient population, so this Center was well-positioned from the start to enroll participants from a broad range of backgrounds in research studies and clinical trials. With the launch of the Center, Mount Sinai moved into the next game-changing phase of research.

Here are highlights from the Center’s first year:

Appointed Helen He, MD, Director of Lasers and Cosmetic Surgery, as Co-Director of the Mount Sinai-Clinique Healthy Skin Center.

Introduced tape strip technology as a non-invasive method for collecting RNA to study and map skin aging and assess anti-aging treatments, applicable in both research and clinical settings.

Proposed using eczema as a disease model to drive translational research and therapeutic innovation in skin aging.

Shared preliminary findings on inflammation in skin and blood of adults over 60, with potential for monoclonal antibody treatments.

Examined advanced cosmetic dermatology tools and treatments offered by the department, including injectables, lasers, and cutting-edge technologies.

Introduced Sofwave, an ultrasound-based device that penetrates the dermis to stimulate collagen production, showing visible results after a single treatment, especially for chin, neck, and arms.

Highlighted Ellacor, a Harvard-invented device performing micro-biopsies to remove 5-10% of skin, achieving great results, particularly for the jawline. It is exclusively offered at this academic center in NYC.

Described the use of multiple lasers tailored for pigmentation treatment across diverse skin types, ensuring effective results for all phenotypes, including Asian and African-American skin.

Obtained non-invasive imaging technologies like VISIA Skin Analysis, optical coherence tomography, confocal microscopy that may be integrated and correlated with molecular tape strip data, and also incorporated in the clinic for standardized clinical assessment and development of personalized anti-aging treatment regimens.

In its next years, the work of the Center will continue as it leverages its connections with other esteemed institutes throughout our health system, including the Precision Immunology Institute at the Icahn School of Medicine (PrIISM) and the Icahn Genomics Institute, to bring their innovative ideas to life. The team also works closely with Mount Sinai’s Skin of Color Center, which is celebrating its 25th anniversary this year, and specializes in diagnosing and treating skin conditions more common in people of color to understand how diseases manifest differently and ensure that treatments are both culturally sensitive and appropriate for differently pigmented skin.

These Year One accomplishments are possible thanks to the vital support and generosity of Clinique, which is grounded in a shared commitment to dermatological research that tangibly improves people’ lives. With a focus on actionable scientific discovery and leading-edge innovation, the Center is well on its way to transform allergy science and pioneer new solutions for skin conditions. Its first year reflects the shared vision between Clinique and Mount Sinai to deliver breakthrough advancements in dermatology that promote healthier skin for all.

Clinique Laboratories' $5M donation to the Icahn School of Medicine established the Mount Sinai-Clinique Healthy Skin Center, focusing on dermatological research. The partnership between Clinique and Mount Sinai aims to advance understanding of skin health, particularly aging and inflammatory conditions. The Center's first year achievements include appointing key personnel, introducing innovative technologies like tape strip RNA collection, and exploring advanced cosmetic dermatology tools. Collaborations with other institutes and a focus on diverse skin types enhance the Center's research impact, aligning with Clinique's mission to improve skin health globally.

Mount Sinai is celebrating one year since the establishment of the Mount Sinai-Clinique Healthy Skin Dermatology Center.

The Mount Sinai-Clinique Healthy Skin Dermatology Center: A First-Year Reflection

I'm sorry, it seems there is no article text provided for me to summarize and analyze. Please provide the text of the article, and I will be happy to assist you

Keith Algozzine

Articles

Latest Updated Articles